Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01631773 · ClinicalTrials.gov registry record
A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 26
- Enrollment target
NCT01631773 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 26 participants.
The verdict
NCT01631773 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
We hypothesize that the miRNA expression in subjects with nasal polyps and Aspirin-exacerbated respiratory disease (AERD) differs from the miRNA expressed in subjects with nasal polyps but without Aspirin-exacerbated respiratory disease (AERD).
Interventions
- GENETIC microRNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01631773
The ClinicalTrials.gov registry entry for NCT01631773 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which microRNA is the first listed.
NCT01631773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01631773 about?
NCT01631773 is a clinical study titled "A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only". We hypothesize that the miRNA expression in subjects with nasal polyps and Aspirin-exacerbated respiratory disease (AERD) differs from the miRNA expressed in subjects with nasal polyps but without Aspirin-exacerbated respiratory disease (AERD).
What is the current status of trial NCT01631773?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2011-08. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01631773?
The interventions under investigation include: microRNA (GENETIC).
Who is sponsoring clinical trial NCT01631773?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.